# Glyphic Biotechnologies

**Canonical:** https://apis.io/providers/glyphic-biotechnologies/  
**Website:** https://glyphic.bio/  
**APIs profiled:** 0

Glyphic Biotechnologies is a Berkeley, California proteomics company founded in 2021 that is developing ProSE (Protein Sequencing by Expansion) — a de novo, high-throughput, single-molecule protein sequencing technology designed to discriminate all 20 amino acids and their post-translational modifications. The company aims to make massively parallel proteome sequencing broadly accessible for drug discovery and biological research, and is backed by Wing Venture Capital. Glyphic currently publishes no public developer API, SDKs, or documentation surface; this profile captures its identity and domain-security posture in the API Evangelist network.

## Kin Score — 10.0 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 10.0).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 4.8 |
| Commercial Clarity | 21.1 |
| Access Clarity | 21.1 |

Regulatory layer — **Health**: 17.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Glyphic Biotechnologies Domain Security** — TLSv1.3 · HSTS · DNSSEC · DMARC

## Tags

Company, Proteomics, Protein Sequencing, Biotechnology, Life Sciences, Single-Molecule Sequencing, Drug Discovery

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/glyphic-biotechnologies/). Scores are computed from the provider's own public artifacts under a published rubric.